Expression, purification, and refolding of a novel immunotoxin containing humanized single-chain fragment variable antibody against CTLA4 and the N-terminal fragment of human perforin.

Lin Wan,Lingyu Zeng,Lihong Chen,Qiang Huang,Shengfu Li,Yanrong Lu,Youping Li,Jingqiu Cheng,Xiaofeng Lu

DOI: https://doi.org/10.1016/j.pep.2006.02.005

IF: 2.025

2006-01-01

Protein Expression and Purification

Abstract:Immunotoxins might be potential in treatment of cancer for their ability to kill selected cell populations. We constructed a novel immunotoxin hS83P34 by fusing N-terminal 34 amino acid fragment of human perforin to the C-terminus of humanized single-chain fragment variable antibody against CTLA4. The fusion protein was inductively expressed as inclusion bodies at a high level about 30% of total bacterial proteins. After washing with buffer containing 2M urea, the purity of inclusion body was about 71%. The washed inclusion bodies were solubilized in 8M urea and further purified to homogeneity (∼92% purity) by cation-exchange chromatography and Ni–agarose affinity chromatography under denaturing condition. The inclusion body refolding conditions were optimized following Pro-Matrix™ Protein Refolding Guide. After refolded in Tris buffer (pH 8.0) containing 1M urea, 0.8M l-arginine, and 2mM GSH:0.2mM GSSG or 2mM GSH:0.4mM GSSG for 18h at 4°C, over 90% proteins were recovered from inclusion bodies. In vitro dose-dependent cytotoxicity assay demonstrates that hS83P34 is only toxic to CTLA4-positive cells. IC50 of hS83P34 for leukemic cells Raji and 6T-CEM are about 0.85 and 1.3μM individually. Whereas, CTLA4-negative endothelial cell ECV-304 is resistant to hS83P34.